The effects of N-methyl-D-aspartate agonists and antagonists on isolated bovine cerebral arteries

Anesthesia and Analgesia

Volumn 82, Issue 2, 1996, Pages 264-268

  Wendling, Woodrow W ^a,b   Chen, Dong ^a   Daniels, Felicia B ^a   Monteforte, Madhavi R ^a   Fischer, Mark B ^a   Harakal, Concerta ^a   Carlsson, Christer ^a  

^a Temple University Health Sciences Center   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; DEXTRORPHAN; DIZOCILPINE; GLUTAMIC ACID; KETAMINE; LEVORPHANOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHOSPHONIC ACID DERIVATIVE; THROMBOXANE A2 DERIVATIVE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CATTLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; STEREOISOMERISM;

ANIMALS; CATTLE; CEREBRAL ARTERIES; DEXTRORPHAN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMATES; KETAMINE; LEVORPHANOL; POTASSIUM; RECEPTORS, N-METHYL-D-ASPARTATE; THROMBOXANE A2; VASOCONSTRICTION; VASODILATION;

EID: 0029670887     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199602000-00009     Document Type: Article

References (28)

1. Yamamura T, Harada K, Okamura A, Kemmotsu O. Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 1990;72:704-10.
2. Daniell LC. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Pharmacol Biochem Behav 1990;36: 111-5.
3. Klepstad P, Maurset A, Moberg ER, Oye I. Evidence of a role for NMDA receptors in pain perception. Bur J Pharmacol 1990;187: 513-8.
4. Lodge D, Johnson KM. Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 1990;11:81-6.
5. Wong EHF, Kemp JA. Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol 1991;1:401-25.
6. Fukuda S, Murakawa T, Takeshita H, Toda N. Direct effects of ketamine on isolated canine cerebral and mesenteric arteries. Anesth Analg 1983;62:553-8.
7. Lu YF, Sun FY, Zhang LM, Zhang AZ. Phencyclidine receptors in porcine cerebral arteries. Acta Pharmacol Sinica 1989;10: 508-11.
8. Wendung WW, Daniels FB, Chen D, et al. Ketamine directly dilates bovine cerebral arteries by acting as a calcium entry blocker. J Neurosurg Anesthesiol 1994;6:186-92.
9. Beart PM, Sheehan K-AM, Manallack DT. Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels. J Cereb Blood Flow Metab 1988;8:879-82.
10. Busija DW, Leffler CW. Dilator effects of amino acid neurotransmitters on piglet pial arterioles. Am J Physiol 1989;257:H1200-3.
11. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 1993;72:476-80.
12. Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology 1972;36:69-75.
13. Cavazzuti M, Porro CA, Biral GP, et al. Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 1987;7:806-11.
14. Perkins WJ, Lanier WL, Karlsson BR, et al. The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia. Brain Res 1989;498:34-44.
15. Takayasu M, Dacey RG Jr. Effects of inhibitory and excitatory amino acid neurotransmitters on isolated cerebral parenchymal arterioles. Brain Res 1989;482:393-6.
16. Hardebo JE, Wieloch T, Kahrstrom J. Excitatory amino acids and cerebrovascular tone. Acta Physiol Scand 1989;136:483-5.
17. Wendung WW, Harakal C. Effects of calcium antagonists on isolated bovine cerebral arteries: inhibition of constriction and calcium-45 uptake induced by potassium or serotonin. Stroke 1987;18:591-8.
18. 2 analogue on bovine cerebral arterial tone and calcium fluxes. Stroke 1991;22:66-72.
19. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989;29:365-402.
20. Kharasch ED, Labroo R. Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 1992;77:1201-7.
21. MacDonald JE, Bartlett MC, Mody I, et al. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurons. J Physiol (Lond) 1991;432: 483-508.
22. Sasaki T, Kassell NF, Fujiwara S, et al. The effects of hyperosmolar solutions on cerebral arterial smooth muscle. Stroke 1986; 17:1266-71.
23. Toda N, Ayajiki K, Toda H, et al. Mechanism underlying mannitol-induced relaxation in isolated monkey: cerebral arteries. Am J Physiol 1992;263(3 Pt 2):H897-902.
24. Lodge D, Anis NA, Burton NR. Effects of optical isomers of ketamine on excitation of cat and rat spinal neurones by amino acids and acetylcholine. Neurosci Lett 1982;29:281-6.
25. Wong EHF, Kemp JA, Priestley T, et al. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 1986;83:7104-8.
26. Church J, Lodge D, Berry SC. Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur J Pharmacol 1985;111:185-90.
27. Martin D, Lodge D. Phencyclidine receptors and N-methyl-D-aspartate antagonism: electrophysiologic data correlates with known behaviors. Pharmacol Biochem Behav 1988;31:279-86.
28. Aram JA, Martin D, Tomczyk M, et al. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exp Therap 1989;248:320-8.